Hiroki Fukuju
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 23, 2026
Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial.Masaki Kato, Kazuyuki Nakagome, Takamichi Baba
|Nov 18, 2025
Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double-blind, randomized, placebo-controlled, Phase 3 clinical trial.Masaki Kato, Kazuyuki Nakagome, Takamichi Baba
|May 03, 2025
Efficacy and safety of SDT-001, a dual-task digital device, in managing attention-deficit/hyperactivity disorder symptoms in children and adolescents: a phase 3, randomized, standard treatment-controlled study.Katsunaka Mikami, Tasuku Miyajima, Ryo Nishino
|Apr 04, 2025
Exploratory study of dual-task digital device in children and adolescents with attention-deficit/hyperactivity disorder.Katsunaka Mikami, Tasuku Miyajima, Ryo Nishino
Pageof 1